Literature DB >> 16172743

Alternagin-C, a disintegrin-like protein from the venom of Bothrops alternatus, modulates alpha2beta1 integrin-mediated cell adhesion, migration and proliferation.

H S Selistre-de-Araujo1, M R Cominetti, C H B Terruggi, A Mariano-Oliveira, M S De Freitas, M Crepin, C C Figueiredo, V Morandi.   

Abstract

The alpha2beta1 integrin is a major collagen receptor that plays an essential role in the adhesion of normal and tumor cells to the extracellular matrix. Alternagin-C (ALT-C), a disintegrin-like protein purified from the venom of the Brazilian snake Bothrops alternatus, competitively interacts with the alpha2beta1 integrin, thereby inhibiting collagen binding. When immobilized in plate wells, ALT-C supports the adhesion of fibroblasts as well as of human vein endothelial cells (HUVEC) and does not detach cells previously bound to collagen I. ALT-C is a strong inducer of HUVEC proliferation in vitro. Gene expression analysis was done using an Affimetrix HU-95A probe array with probe sets of approximately 10,000 human genes. In human fibroblasts growing on collagen-coated plates, ALT-C up-regulates the expression of several growth factors including vascular endothelial growth factor, as well as some cell cycle control genes. Up-regulation of the vascular endothelial growth factor gene and other growth factors could explain the positive effect on HUVEC proliferation. ALT-C also strongly activates protein kinase B phosphorylation, a signaling event involved in endothelial cell survival and angiogenesis. In human neutrophils, ALT-C has a potent chemotactic effect modulated by the intracellular signaling cascade characteristic of integrin-activated pathways. Thus, ALT-C acts as a survival factor, promoting adhesion, migration and endothelial cell proliferation after binding to alpha2beta1 integrin on the cell surface. The biological activities of ALT-C may be helpful as a therapeutic strategy in tissue regeneration as well as in the design of new therapeutic agents targeting alpha2beta1 integrin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172743     DOI: 10.1590/s0100-879x2005001000007

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  15 in total

1.  Expression, purification, and analysis of three recombinant ECD disintegrins (r-colombistatins) from P-III class snake venom metalloproteinases affecting platelet aggregation and SK-MEL-28 cell adhesion.

Authors:  Montamas Suntravat; Thomas J Helmke; Chairat Atphaisit; Esteban Cuevas; Sara E Lucena; Nestor L Uzcátegui; Elda E Sánchez; Alexis Rodriguez-Acosta
Journal:  Toxicon       Date:  2016-09-15       Impact factor: 3.033

2.  Functional analysis of a recombinant PIII-SVMP, GST-acocostatin; an apoptotic inducer of HUVEC and HeLa, but not SK-Mel-28 cells.

Authors:  Takele Teklemariam; Agustin I Seoane; Carla J Ramos; Elda E Sanchez; Sara E Lucena; John C Perez; Stephanie A Mandal; Julio G Soto
Journal:  Toxicon       Date:  2011-01-19       Impact factor: 3.033

3.  Anti-invasive and anti-adhesive activities of a recombinant disintegrin, r-viridistatin 2, derived from the Prairie rattlesnake (Crotalus viridis viridis).

Authors:  Sara E Lucena; Ying Jia; Julio G Soto; Jessica Parral; Esteban Cantu; Jeremy Brannon; Kristina Lardner; Carla J Ramos; Agustin I Seoane; Elda E Sánchez
Journal:  Toxicon       Date:  2012-03-21       Impact factor: 3.033

4.  Anti-metastatic activity of the recombinant disintegrin, r-mojastin 1, from the Mohave rattlesnake.

Authors:  Sara Lucena; Elda E Sanchez; John C Perez
Journal:  Toxicon       Date:  2011-02-18       Impact factor: 3.033

5.  Rat skin wound healing induced by alternagin-C, a disintegrin-like, Cys-rich protein from Bothrops alternatus venom.

Authors:  Estela Maria Correia Sant'Ana; Cibele Marli Cação Paiva Gouvêa; João Luiz Quagliotti Durigan; Márcia Regina Cominetti; Edson Rosa Pimentel; Heloisa Sobreiro Selistre-de-Araújo
Journal:  Int Wound J       Date:  2011-03-10       Impact factor: 3.315

6.  A transcriptomic analysis of gene expression in the venom gland of the snake Bothrops alternatus (urutu).

Authors:  Kiara C Cardoso; Márcio J Da Silva; Gustavo G L Costa; Tatiana T Torres; Luiz Eduardo V Del Bem; Ramon O Vidal; Marcelo Menossi; Stephen Hyslop
Journal:  BMC Genomics       Date:  2010-10-26       Impact factor: 3.969

7.  Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3.

Authors:  Nareerat Petpiroon; Boonchoo Sritularak; Pithi Chanvorachote
Journal:  BMC Complement Altern Med       Date:  2017-12-29       Impact factor: 3.659

8.  Alternagin-C (ALT-C), a Disintegrin-Like Cys-Rich Protein Isolated from the Venom of the Snake Rhinocerophis alternatus, Stimulates Angiogenesis and Antioxidant Defenses in the Liver of Freshwater Fish, Hoplias malabaricus.

Authors:  Diana Amaral Monteiro; Heloisa Sobreiro Selistre-de-Araújo; Driele Tavares; Marisa Narciso Fernandes; Ana Lúcia Kalinin; Francisco Tadeu Rantin
Journal:  Toxins (Basel)       Date:  2017-09-28       Impact factor: 4.546

9.  BaltDC: purification, characterization and infrared spectroscopy of an antiplatelet DC protein isolated from Bothrops alternatus snake venom.

Authors:  Mariana Santos Matias; Bruna Barbosa de Sousa; Déborah Fernanda da Cunha Pereira; Edigar Henrique Vaz Dias; Carla Cristine Neves Mamede; Mayara Ribeiro de Queiroz; Anielle Christine Almeida Silva; Noelio Oliveira Dantas; Andreimar Martins Soares; Júnia de Oliveira Costa; Fábio de Oliveira
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-07-28

10.  Copper (II) and 2,2'-bipyridine complexation improves chemopreventive effects of naringenin against breast tumor cells.

Authors:  Júlio César Conceição Filho; André Lúcio Franceschini Sarria; Amanda Blanque Becceneri; Angelina Maria Fuzer; Jaqueline Raquel Batalhão; Caio Marcio Paranhos da Silva; Rose Maria Carlos; Paulo Cezar Vieira; João Batista Fernandes; Márcia Regina Cominetti
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.